Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Liver
»
Neoplasms
01. June 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Hepatitis
Liver Cirrhosis
Neoplasms
Portal Hypertension
Others
Gastrointestinal
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 3814
Articles 1 - 20 / 76267
Aflatoxin B1 and food safety: Mechanisms of action associated to Hepatocellular Carcinoma.
Arch Microbiol
Zamudio MC, Balleza D.
PMID: 42223606 [PubMed - indexed for MEDLINE]
First-line immunotherapy for advanced hepatocellular carcinoma: a network meta-analysis of randomized trials with overall and HBV/HCV-stratified efficacy and safety.
Front Immunol
Chen W, Chen B, Hu C, Wei Q, Zhang L, Fu W.
PMID: 42220514 [PubMed - indexed for MEDLINE]
MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma.
Front Immunol
An X, Gao Y, Zhao S, He W, Yang X, Wu Y, Li J, Yi R, Han Y, Li M, Li Q, Yang T.
PMID: 42220486 [PubMed - indexed for MEDLINE]
Current and Future Landscape of Hepatocellular Carcinoma Treatment.
Oncol Res
Zerehpoosh S, Tanaka Y, Al-Busafi SA, Aghayeva G, Rouabhia S, Pan Q, Eslam M.
PMID: 42220430 [PubMed - indexed for MEDLINE]
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma.
Liver Int
Meischl T, Steurer M, Balcar L, Marcour Y, Meier P, Bucher L, Park YR, Pomej K, Mandorfer M, Reiberger T, Trauner M, Scheiner B, Pinter M.
PMID: 42220216 [PubMed - indexed for MEDLINE]
Excellent Outcomes With High-Risk Pediatric Hepatoblastoma: A Detailed Analysis of a Large, Single-Center Experience.
Pediatr Transplant
Ripa V, Venick RS, Ebaid S, Federman N, Charland N, Thornley CJ, Jou J, Pearson B, Agopian VG, Kaldas FM, McDiarmid SV, Farmer DG.
PMID: 42220061 [PubMed - indexed for MEDLINE]
Foxp3+/CD4+ Cell Ratio in Primary Colorectal Cancer Predicts Opposite Prognoses Following Resection of Synchronous or Metachronous Liver Metastases.
Cancer Med
Trailin A, Ali E, Pavlov S, Ye W, , Vy, Ambrozkiewicz F, Ji, Daum O, Li, Hemminki K.
PMID: 42216261 [PubMed - indexed for MEDLINE]
Resveratrol's hepatic symphony: conducting a multi-stage intervention in liver cancer's progression.
Chin J Nat Med
Guo C, Cao F, Zhou L, Guo G, Zheng S, Xia R, Zou Q.
PMID: 42215151 [PubMed - indexed for MEDLINE]
Durable Survival Outcomes After Liver Transplantation for Colorectal Liver Metastases: A Systematic Review and Single-arm Meta-analysis of Prospective Clinical Trials.
J Gastrointest Cancer
Saqib HW, Siddiq N, Moazzam M, Hamza M, Ahmad M, Omer M, Khan T, Iqbal MF, Murad A, Khan RA, Bhatti ABH.
PMID: 42213206 [PubMed - indexed for MEDLINE]
Burnt-Out MASLD Predicts Outcomes After Curative Resection for Hepatocellular Carcinoma.
Liver Int
Watanabe Y, Aikawa M, Murase Y, Oba T, Kageyama Y, Takase K, Watanabe Y, Ono H, Okada K, Okamoto K, Koyama I.
PMID: 42212428 [PubMed - indexed for MEDLINE]
Targeting lactylation in hepatocellular carcinoma: Mechanistic insights and therapeutic opportunities (Review).
Int J Mol Med
Chen L, Gao F, Mei Q, Li Y, Cai Q, Feng X.
PMID: 42212387 [PubMed - indexed for MEDLINE]
Machine learning-based prediction of hepatocellular carcinoma risk in steatotic liver disease: A nationwide cohort study.
PLoS One
Kim LY, Lee JS, Yoo JJ, Cho EJ, Kim SG, Kim YS.
PMID: 42207764 [PubMed - indexed for MEDLINE]
Frequency and associated factors of hepatic hemangioma in systemic lupus erythematosus patients undergoing abdominal imaging: a retrospective cohort study.
Rheumatol Int
Üsküdar Cansu D, Uludo, Y, Önal Birtane G, Y, Özbayrak U, Korkmaz C.
PMID: 42207195 [PubMed - indexed for MEDLINE]
Sintilimab plus fruquintinib with or without radiotherapy for third-line treatment of colorectal cancer with liver metastases: study protocol for a randomized controlled, multicenter phase II trial.
Front Immunol
Ma Z, Zhu K, Shi F, Feng R, Jiang S, Dou X, Liu J, Niu Z, Yue J.
PMID: 42206059 [PubMed - indexed for MEDLINE]
Comprehensive analysis based on tertiary lymphoid structures and tumor budding predicts survival rates in colorectal cancer patients with synchronous liver metastases.
Front Immunol
Zhang J, Zhu H, Qian L, Liang M, Miao J, Zhu H, Shen X, Mao Y, Li Q.
PMID: 42206052 [PubMed - indexed for MEDLINE]
Strategies for enhancing delivery efficiency on MR-Linac: A dosimetric study and historical plan review.
J Appl Clin Med Phys
Zhang Y, Tang S, Kabat C, Visak J, Chiu T, Li R, Jiang S, Lin MH.
PMID: 42204767 [PubMed - indexed for MEDLINE]
Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.
Gastroenterol Clin North Am
Spaggiari M, Kortan E, Alaniz MJ.
PMID: 42203398 [PubMed - indexed for MEDLINE]
Clustering of quantitative CT features identifies HCC subtypes with distinct prognosis and immune signatures.
Eur Radiol Exp
Wu S, Peng F, Huang J, Xu L, Zhang X, Bao Y, Chen Y.
PMID: 42201507 [PubMed - indexed for MEDLINE]
Risk Factors for Hepatocellular Carcinoma in Latino Populations in Texas: A Scoping Review.
Int J Mol Sci
Tuzino Kamia LY, Gonzalez E, Swanson CM, Gomez SL, Canales AM, Price RS.
PMID: 42196623 [PubMed - indexed for MEDLINE]
Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications.
Int J Mol Sci
Liapopoulos D, Sarantis P, Zogas G, Trifylli EM, Bousou TE, Kamitaki K, Anastasiou IA, Kokkali S, Mavromatis S, Koustas E, Elefsiniotis I, Biniari T, Karamouzis MV.
PMID: 42196608 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 76267
Page 1 of 3814
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy